Lixte Biotechnology Holdings, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
LIXT, LIXTW on Nasdaq
Industry
Pharmaceutical Preparations
Location
248 Route 25 A, No. 2, East Setauket, NY

There are no Buy or Sell transactions made by insiders since 11/8/2023

Lixte Biotechnology Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Glenn Krinsky 10%+ Owner $3.7M Dec 17, 2021
Gil Schwartzberg Director, 10%+ Owner $2.95M Dec 31, 2021
Bastiaan van der Baan President and CEO, Director $27.6K Oct 3, 2023
Philip Palmedo Director Jun 30, 2022
Eric Forman Vice President and COO Dec 9, 2022
Rene Bernards Director Sep 30, 2024
Robert Weingarten Vice President and CFO Nov 6, 2022
Regina Brown Director Sep 30, 2024
Stephen Forman Director Sep 30, 2024
Johannes Henricus Matthias Schellens Chief Medical Officer Aug 1, 2024
Yun Yen Director Sep 30, 2024
John Kovach President and CEO, Director Nov 6, 2022
James Miser Chief Medical Officer Nov 6, 2022

Recent Insider Transactions by Companies or Individuals for Lixte Biotechnology Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.